Core B is a Neuropathology and Biomarker Core (NP Core) that plays a vital role in the UCSF FTD PPG. FTLD neuropathology has become increasingly exciting and complex in recent years, with major advances arising from work accomplished through this PPG. In this renewal application, we propose to continue to cultivate a world-class FTLD-oriented neurodegenerative disease brain bank at UCSF. The NP Core aims to: (1) Obtain CNS tissue for NP characterization and banking by performing timely autopsies on patients and healthy controls ascertained through the Clinical Core; (2) Analyze specimens and document NP diagnoses by dissecting a standard set of 23 tissue blocks for routine histological staining and systematic immunohistochemical characterization, resulting in semi-quantitative and quantitative assessments; (3) Enter NP findings into a comprehensive research-oriented database; (4) Bank CNS tissues, blood, plasma, and CSF, analyze CSF for putative diagnostic biomarkers, and distribute biospecimens to qualified investigators; (5) Engage with PPG collaborators in conducting FTLD clinico-pathological research by meeting regularly with PPG Project leaders who rely on NP Core data; and (6) Train the next generation of neuropathology leaders and clinical scientists grounded in neuropathology principles and methods by holding consensus and clinico- pathological conferencesThese core functions will support the aims of Projects 3 (Emotions), 4 (Clinical criteria), and 7 (Language) by providing final neuropathological diagnoses that serve as primary outcomes or grouping variables as well as semi-quantitative and/or quantitative regional pathological data. Moreover, the NP Core will help to further develop a unique bank of specially handled CNS tissues (brain, spinal cord, and CSF) for ongoing and future FTLD molecular, translational, clinicopathological, and biomarker discovery research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG019724-19
Application #
9949601
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
19
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Zakrzewski, Jessica J; Datta, Samir; Scherling, Carole et al. (2018) Deficits in physiological and self-conscious emotional response to errors in hoarding disorder. Psychiatry Res 268:157-164
Rojas, Julio C; Bang, Jee; Lobach, Iryna V et al. (2018) CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. Neurology 90:e273-e281
Hua, Alice Y; Sible, Isabel J; Perry, David C et al. (2018) Enhanced Positive Emotional Reactivity Undermines Empathy in Behavioral Variant Frontotemporal Dementia. Front Neurol 9:402
Miller, Zachary A; Rosenberg, Lynne; Santos-Santos, Miguel A et al. (2018) Prevalence of Mathematical and Visuospatial Learning Disabilities in Patients With Posterior Cortical Atrophy. JAMA Neurol 75:728-737
Rojas, Julio C; Stephens, Melanie L; Rabinovici, Gil D et al. (2018) Multiproteinopathy, neurodegeneration and old age: a case study. Neurocase 24:1-6
Dijkstra, Anke A; Lin, Li-Chun; Nana, Alissa L et al. (2018) Von Economo Neurons and Fork Cells: A Neurochemical Signature Linked to Monoaminergic Function. Cereb Cortex 28:131-144
Mok, Sue-Ann; Condello, Carlo; Freilich, Rebecca et al. (2018) Mapping interactions with the chaperone network reveals factors that protect against tau aggregation. Nat Struct Mol Biol 25:384-393
Erkkinen, Michael G; Zúñiga, Raquel Gutiérrez; Pardo, Cristóbal Carnero et al. (2018) Artistic Renaissance in Frontotemporal Dementia. JAMA 319:1304-1306
Schneider, Raphael; McKeever, Paul; Kim, TaeHyung et al. (2018) Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. J Neurol Neurosurg Psychiatry 89:851-858
Ljubenkov, Peter A; Staffaroni, Adam M; Rojas, Julio C et al. (2018) Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory. Ann Clin Transl Neurol 5:1250-1263

Showing the most recent 10 out of 607 publications